More about
Refractory Myelodysplastic Syndromes
News
October 25, 2023
2 min read
Save
FDA approves Tibsovo for treatment of advanced myelodysplastic syndromes
The FDA approved ivosidenib for treatment of certain adults with relapsed or refractory myelodysplastic syndromes.